ANVS - Wall Street Estimates - Annovis Bio, Inc.

Healthcare - Biotechnology - NYSE - US

$ 4.9993

2.24 %

$ 69 M

Market Cap

-1.18

P/E

Price Target Average

413.41%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

37.69%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Annovis Bio, Inc.

Wall Street analysts predict an average 1-year price target for ANVS of $25.7 , with forecasts ranging from a low of $21 to a high of $30 .

ANVS Lowest Price Target Wall Street Target

21 USD 320.06%

ANVS Average Price Target Wall Street Target

25.7 USD 413.41%

ANVS Highest Price Target Wall Street Target

30 USD 500.08%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free